免疫调节药物治疗多发性骨髓瘤发生深静脉血栓风险的系统评价和Meta分析(4)
[ 3 ] MOHER D,LIBERATI A,TETZLAFF J,et al. Preferred reporting items for systematic reviews and meta-analyses:the PRISMA statement[J]. BMJ,2009.DOI:http://doi.org/10136/bnj62535.[ 4 ] RAJKUMAR SV,DIMOPOULOS MA,PALUMBO A, et al. International myeloma working group updated criteria for the diagnosis of multiplemyeloma[J]. Lancet Oneol,2014,15(12):e538-e548.
[ 5 ] 中国医师协会血液科医师分会,中华医学会血液学分会 ......
您现在查看是摘要页,全文长 3559 字符。